Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor

Yuan-Yun Tseng, Yang Lan Lo, Lih Huei Chen, Po Liang Lai, Shung-Tai Yang

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Metastases to the spine are a common problem in the large oncology center and represent a challenging problem in oncology practice. Patients with osteolytic metastases often experience intractable local and/or radicular pain. Therapeutic intervention can alleviate pain, preserve or improve neurologic function, achieve mechanical stability, and improve quality of life. Percutaneous polymethylmethacrylate vertebroplasty is an effective and relatively easy method of relieving patients' pain. Method: Between January 2002 and December 2006, 57 patients (78 vertebrae) with spinal metastatic tumor treated with PMMA vertebroplasty were enrolled in this study. The main indication for treatment was pain. Result: The mean value of VAS was 8.1 ± 0.67 preoperatively, and it significantly decreased to 3.8 ± 1.9 (1-8, P <.015) 1 day after vertebroplasty. The mean VAS value 6 months after vertebroplasty was 2.8 ± 2.0 (P <.001). The mean amounts of preoperative nonnarcotic analgesic and narcotic analgesic were 1.98 ± 1.4 and 1.19 ± 0.73, respectively. Postoperatively, the mean amounts of nonnarcotic and narcotic analgesic decreased to 1.35 ± 0.70 (P <.05) and 0.65 ± 0.53 (P <.05). A statistically significant reduction of nonnarcotic analgesic use was noticed in our study. Conclusions: Percutaneous vertebroplasty is a minimally invasive procedure that offers a remarkable advantage of effective and immediate pain relief with few complications.

Original languageEnglish
Pages (from-to)S78-S83
JournalSurgical Neurology
Volume70
Issue numberSUPPL. 1
DOIs
Publication statusPublished - Dec 2008
Externally publishedYes

Fingerprint

Vertebroplasty
Polymethyl Methacrylate
Non-Narcotic Analgesics
Spine
Pain
Narcotics
Neoplasms
Neoplasm Metastasis
Therapeutics
Nervous System
Quality of Life

Keywords

  • Pain
  • Spinal instability
  • Spinal metastatic tumor
  • Vertebroplasty

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor. / Tseng, Yuan-Yun; Lo, Yang Lan; Chen, Lih Huei; Lai, Po Liang; Yang, Shung-Tai.

In: Surgical Neurology, Vol. 70, No. SUPPL. 1, 12.2008, p. S78-S83.

Research output: Contribution to journalArticle

@article{a42c522fb64c4fe18a0adf34cea60d86,
title = "Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor",
abstract = "Background: Metastases to the spine are a common problem in the large oncology center and represent a challenging problem in oncology practice. Patients with osteolytic metastases often experience intractable local and/or radicular pain. Therapeutic intervention can alleviate pain, preserve or improve neurologic function, achieve mechanical stability, and improve quality of life. Percutaneous polymethylmethacrylate vertebroplasty is an effective and relatively easy method of relieving patients' pain. Method: Between January 2002 and December 2006, 57 patients (78 vertebrae) with spinal metastatic tumor treated with PMMA vertebroplasty were enrolled in this study. The main indication for treatment was pain. Result: The mean value of VAS was 8.1 ± 0.67 preoperatively, and it significantly decreased to 3.8 ± 1.9 (1-8, P <.015) 1 day after vertebroplasty. The mean VAS value 6 months after vertebroplasty was 2.8 ± 2.0 (P <.001). The mean amounts of preoperative nonnarcotic analgesic and narcotic analgesic were 1.98 ± 1.4 and 1.19 ± 0.73, respectively. Postoperatively, the mean amounts of nonnarcotic and narcotic analgesic decreased to 1.35 ± 0.70 (P <.05) and 0.65 ± 0.53 (P <.05). A statistically significant reduction of nonnarcotic analgesic use was noticed in our study. Conclusions: Percutaneous vertebroplasty is a minimally invasive procedure that offers a remarkable advantage of effective and immediate pain relief with few complications.",
keywords = "Pain, Spinal instability, Spinal metastatic tumor, Vertebroplasty",
author = "Yuan-Yun Tseng and Lo, {Yang Lan} and Chen, {Lih Huei} and Lai, {Po Liang} and Shung-Tai Yang",
year = "2008",
month = "12",
doi = "10.1016/j.surneu.2008.08.078",
language = "English",
volume = "70",
pages = "S78--S83",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Percutaneous polymethylmethacrylate vertebroplasty in the treatment of pain induced by metastatic spine tumor

AU - Tseng, Yuan-Yun

AU - Lo, Yang Lan

AU - Chen, Lih Huei

AU - Lai, Po Liang

AU - Yang, Shung-Tai

PY - 2008/12

Y1 - 2008/12

N2 - Background: Metastases to the spine are a common problem in the large oncology center and represent a challenging problem in oncology practice. Patients with osteolytic metastases often experience intractable local and/or radicular pain. Therapeutic intervention can alleviate pain, preserve or improve neurologic function, achieve mechanical stability, and improve quality of life. Percutaneous polymethylmethacrylate vertebroplasty is an effective and relatively easy method of relieving patients' pain. Method: Between January 2002 and December 2006, 57 patients (78 vertebrae) with spinal metastatic tumor treated with PMMA vertebroplasty were enrolled in this study. The main indication for treatment was pain. Result: The mean value of VAS was 8.1 ± 0.67 preoperatively, and it significantly decreased to 3.8 ± 1.9 (1-8, P <.015) 1 day after vertebroplasty. The mean VAS value 6 months after vertebroplasty was 2.8 ± 2.0 (P <.001). The mean amounts of preoperative nonnarcotic analgesic and narcotic analgesic were 1.98 ± 1.4 and 1.19 ± 0.73, respectively. Postoperatively, the mean amounts of nonnarcotic and narcotic analgesic decreased to 1.35 ± 0.70 (P <.05) and 0.65 ± 0.53 (P <.05). A statistically significant reduction of nonnarcotic analgesic use was noticed in our study. Conclusions: Percutaneous vertebroplasty is a minimally invasive procedure that offers a remarkable advantage of effective and immediate pain relief with few complications.

AB - Background: Metastases to the spine are a common problem in the large oncology center and represent a challenging problem in oncology practice. Patients with osteolytic metastases often experience intractable local and/or radicular pain. Therapeutic intervention can alleviate pain, preserve or improve neurologic function, achieve mechanical stability, and improve quality of life. Percutaneous polymethylmethacrylate vertebroplasty is an effective and relatively easy method of relieving patients' pain. Method: Between January 2002 and December 2006, 57 patients (78 vertebrae) with spinal metastatic tumor treated with PMMA vertebroplasty were enrolled in this study. The main indication for treatment was pain. Result: The mean value of VAS was 8.1 ± 0.67 preoperatively, and it significantly decreased to 3.8 ± 1.9 (1-8, P <.015) 1 day after vertebroplasty. The mean VAS value 6 months after vertebroplasty was 2.8 ± 2.0 (P <.001). The mean amounts of preoperative nonnarcotic analgesic and narcotic analgesic were 1.98 ± 1.4 and 1.19 ± 0.73, respectively. Postoperatively, the mean amounts of nonnarcotic and narcotic analgesic decreased to 1.35 ± 0.70 (P <.05) and 0.65 ± 0.53 (P <.05). A statistically significant reduction of nonnarcotic analgesic use was noticed in our study. Conclusions: Percutaneous vertebroplasty is a minimally invasive procedure that offers a remarkable advantage of effective and immediate pain relief with few complications.

KW - Pain

KW - Spinal instability

KW - Spinal metastatic tumor

KW - Vertebroplasty

UR - http://www.scopus.com/inward/record.url?scp=56849116563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56849116563&partnerID=8YFLogxK

U2 - 10.1016/j.surneu.2008.08.078

DO - 10.1016/j.surneu.2008.08.078

M3 - Article

AN - SCOPUS:56849116563

VL - 70

SP - S78-S83

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - SUPPL. 1

ER -